Michael K. Hilinski, Ph.D. - Publications

2007 Stanford University, Palo Alto, CA 
Organic, Organometallic, Bioorganic, and Medicinal Chemistry

15 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Laudenschlager JE, Combee LA, Hilinski MK. Intermolecular scandium triflate-promoted nitrene-transfer [5 + 1] cycloadditions of vinylcyclopropanes. Organic & Biomolecular Chemistry. PMID 31641723 DOI: 10.1039/C9Ob01858A  1
2019 Combee LA, Johnson SL, Laudenschlager JE, Hilinski MK. Rh(II)-Catalyzed Nitrene-Transfer [5 + 1] Cycloadditions of Aryl-Substituted Vinylcyclopropanes. Organic Letters. PMID 30907595 DOI: 10.1021/Acs.Orglett.9B00594  1
2018 Combee LA, Raya B, Wang D, Hilinski MK. Organocatalytic nitrenoid transfer: metal-free selective intermolecular C(sp)-H amination catalyzed by an iminium salt. Chemical Science. 9: 935-939. PMID 29629160 DOI: 10.1039/C7Sc03968A  1
2018 Dyer RMB, Hahn PL, Hilinski MK. Selective Heteroaryl N-Oxidation of Amine-Containing Molecules. Organic Letters. PMID 29547294 DOI: 10.1021/Acs.Orglett.8B00558  1
2017 Shuler WG, Johnson SL, Hilinski MK. Organocatalytic, Dioxirane-Mediated C-H Hydroxylation under Mild Conditions Using Oxone. Organic Letters. PMID 28841323 DOI: 10.1021/Acs.Orglett.7B02178  0.56
2016 Wang D, Shuler WG, Pierce CJ, Hilinski MK. An Iminium Salt Organocatalyst for Selective Aliphatic C-H Hydroxylation. Organic Letters. PMID 27391543 DOI: 10.1021/Acs.Orglett.6B01832  0.76
2014 Pierce CJ, Hilinski MK. Chemoselective hydroxylation of aliphatic sp3 C-H bonds using a ketone catalyst and aqueous H2O2. Organic Letters. 16: 6504-7. PMID 25479376 DOI: 10.1021/Ol503410E  0.76
2012 Mrozowski RM, Vemula R, Wu B, Zhang Q, Schroeder BR, Hilinski MK, Clark DE, Hecht SM, O'Doherty GA, Lannigan DA. Improving the affinity of SL0101 for RSK using structure-based design. Acs Medicinal Chemistry Letters. 4: 175-179. PMID 23519677 DOI: 10.1021/Ml300298V  0.76
2012 Utepbergenov D, Derewenda U, Olekhnovich N, Szukalska G, Banerjee B, Hilinski MK, Lannigan DA, Stukenberg PT, Derewenda ZS. Insights into the inhibition of the p90 ribosomal S6 kinase (RSK) by the flavonol glycoside SL0101 from the 1.5 Å crystal structure of the N-terminal domain of RSK2 with bound inhibitor. Biochemistry. 51: 6499-510. PMID 22846040 DOI: 10.1021/Bi300620C  0.76
2012 Hilinski MK, Mrozowski RM, Clark DE, Lannigan DA. Analogs of the RSK inhibitor SL0101: optimization of in vitro biological stability. Bioorganic & Medicinal Chemistry Letters. 22: 3244-7. PMID 22464132 DOI: 10.1016/J.Bmcl.2012.03.033  0.76
2008 Mooberry SL, Hilinski MK, Clark EA, Wender PA. Function-oriented synthesis: biological evaluation of laulimalide analogues derived from a last step cross metathesis diversification strategy. Molecular Pharmaceutics. 5: 829-38. PMID 18662015 DOI: 10.1021/Mp800043N  0.76
2006 Wender PA, Hilinski MK, Skaanderup PR, Soldermann NG, Mooberry SL. Pharmacophore mapping in the laulimalide series: total synthesis of a vinylogue for a late-stage metathesis diversification strategy. Organic Letters. 8: 4105-8. PMID 16928085 DOI: 10.1021/Ol061619U  0.76
2006 Wender PA, Hilinski MK, Soldermann N, Mooberry SL. Total synthesis and biological evaluation of 11-desmethyllaulimalide, a highly potent simplified laulimalide analogue. Organic Letters. 8: 1507-10. PMID 16562928 DOI: 10.1021/Ol060233G  0.76
2006 Wender PA, Baryza JL, Hilinski MK, Horan JC, Kan C, Verma VA. Beyond Natural Products: Synthetic Analogues of Bryostatin 1 Drug Discovery Research: New Frontiers in the Post-Genomic Era. 125-162. DOI: 10.1002/9780470131862.ch6  0.76
2005 Wender PA, Hilinski MK, Mayweg AV. Late-stage intermolecular CH activation for lead diversification: a highly chemoselective oxyfunctionalization of the C-9 position of potent bryostatin analogues. Organic Letters. 7: 79-82. PMID 15624982 DOI: 10.1021/Ol047859W  0.76
Show low-probability matches.